Inhibiting mevalonate pathway enzymes increases stromal cell resilience to a cholesterol-dependent cytolysin. | Sci Rep;7(1): 17050, 2017 12 06. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Inhibiting mevalonate pathway enzymes increases stromal cell resilience to a cholesterol-dependent cytolysin.

Griffin, Sholeem; Preta, Giulio; Sheldon, Iain Martin.

Affiliation

Griffin S; Swansea University Medical School, Swansea University, Swansea, SA2 8PP, United Kingdom.
Preta G; Swansea University Medical School, Swansea University, Swansea, SA2 8PP, United Kingdom.
Sheldon IM; Institute of Biochemistry, Vilnius University, Sauletekio 7, Vilnius LT-10257, Lithuania.

Sci Rep ; 7(1): 17050, 2017 12 06.

Article in En | MEDLINE | ID: mdl-29213055

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Proteins / Bacterial Toxins / Cholesterol / Hemolysin Proteins / Mevalonic Acid Limits: Animals / Humans Language: En Journal: Sci Rep Year: 2017 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Proteins / Bacterial Toxins / Cholesterol / Hemolysin Proteins / Mevalonic Acid Limits: Animals / Humans Language: En Journal: Sci Rep Year: 2017 Document type: Article Affiliation country: